North America Biosimilars Market Future Projection, Comprehensive Study, Forecasts -2028
The North America biosimilars market is expected to grow from US$ 7,115.74 million in 2022 to US$ 47,746.80 million by 2028. It is estimated to grow at a CAGR of 37.3% from 2022 to 2028.
North America’s Biosimilars Market: Key Insights
Autoimmune diseases are also on the rise in the region. According to the NIH Autoimmune Diseases Coordinating Committee, over 24 million Americans...